Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
AnaptysBio, Inc.
Business Segments
Business Segments
Net Income Loss
Net Income Loss
AnaptysBio, Inc.
·
Business Segments
·
2 segments
·
Rolls up to
Net Income
Breakdown
Segments
Biopharma Company
View metric
Royalty Management Company
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q1 '26
Biopharma Company
-$50.48M
Royalty Management Company
-$2.4M
Total
-$52.88M
